abs88.txt	objective		to	investigate	the	use	of	5α-reductase	inhibitors	(5aris)	andα-blockers	among	men	with	benign	prostatic	hyperplasia	(bph)	in	relation	toprostate	cancer	(pca)	incidence	severity	and	mortality	patients	methods	a	retrospective	20-year	cohort	study	residing	insaskatchewan	aged	40-89	years	bph-coded	medical	claim	between	1995	and2014	was	conducted	cox	proportional	hazards	regression	used	compareincidence	pca	diagnosis	metastatic	gleason	score	8-10	pcamortality	5ari	users	(n	=	4	571)	α-blocker	7	764)	non-users(n	11	677)	results	comparison	both	non-users	had	a~40%	lower	risk	(11	0%	4%	vs	5	8%	respectively)	andα-blocker	an	11%	compared	overall	not	significantlydifferent	or	(adjusted	hazardratios	[hr]	1	12	13	respectively	18	p	>	0	05	for	drugs)	but	anda-blocker	~30%	higher	adjusted	hr1	37	95%	confidence	interval	[ci]	03-1	82	03	hr	28	95%ci	59	02	conclusion	5aris	associated	regardless	group	high	grade	5ariusers	however	this	did	nottranslate	into
